DTC Ad Endorsement Policy Should Be Consistent With OTC Practice – FTC
This article was originally published in The Tan Sheet
Executive Summary
Endorsements and testimonials in direct-to-consumer advertising for prescription drugs should be subject to the same standards the Federal Trade Commission applies to OTC drug ads, FTC advises in Dec. 1 comments to the agency
You may also be interested in...
DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising
DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising
DTC Advertising’s Blurred Line: Rx Spots Look A Lot Like OTC Promotions
Competition in the heartburn/GERD category between prescription and OTC drugs illustrates the increasing similarities between over-the-counter and Rx direct-to-consumer advertising